Geode Capital Management, LLC Acurx Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 146,500 shares of ACXP stock, worth $114,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146,500
Previous 146,500
-0.0%
Holding current value
$114,270
Previous $278,000
57.55%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ACXP
# of Institutions
31Shares Held
1.42MCall Options Held
13.6KPut Options Held
4K-
Vanguard Group Inc Valley Forge, PA529KShares$412,8920.0% of portfolio
-
Prospect Financial Services LLC Melville, NY329KShares$256,6790.15% of portfolio
-
Morgan Stanley New York, NY106KShares$82,8360.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA48.4KShares$37,7310.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$33,9030.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $9.01M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...